Mechanistically, scientific literature suggests BPC 157 may influence several repair pathways at once, including signaling involved in new blood vessel formation (angiogenesis), nitric oxide-related pathways (important for blood flow and tissue signaling), and growth-factor activity that supports cell migration and remodeling during healing
More commonly used than droxidopa: Midodrine was approved in the 1990s (droxidopa was approved in 2014) Most clinicians have longer experience with midodrine Midodrine is available as a generic & is less expensive Droxidopa is typically reserved for use as an add-on when midodrine is ineffective, or midodrine is not tolerated due to side effects Contraindications: hypertension heart failure acute kidney failure urinary retention thyrotoxicosis pheochromocytoma Side Effects: Supine hypertension WARNING : may cause marked hypertension when the patient is supine (laying down)
Plaque Excision and Grafting Removing the fibrous plaque and replacing it with graft material
Epigenetic and Cellular Reprogramming: By blocking NNMT-mediated methylation of nicotinamide, preserves NAD salvage pathway activity, increases SIRT-1 signaling, reduces histone deacetylation, and promotes metabolic reprogramming toward oxidative phosphorylation and glycolysis balance, supporting tissue repair and energy homeostasis 1-4
.jpeg)
